Skip to main content
Clinical Trials/CTRI/2022/09/045203
CTRI/2022/09/045203
Not yet recruiting
Phase 2

Pharmaceutico- analytical and comparative clinical study of dadrudrawanal lepa and dadrudrawanal cream in patients of dadru (dermatophytosis )

ational Institute of Ayurveda Deemed to be University De novo0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
ational Institute of Ayurveda Deemed to be University De novo
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
ational Institute of Ayurveda Deemed to be University De novo

Eligibility Criteria

Inclusion Criteria

  • 1\. Patient of either sex in the age group of 18\-60 Years.
  • 2\. Patients having signs and symptoms of Dadru like Kandu and Raga Yukta Pidika and Mandala.
  • 3\. Patients of Tinea cruris and localized Tinea corporis will be included in the trial.
  • ââ?¬Â¢Patients having demonstrable Fungal hyphae in KOH (Skin scarping examination)

Exclusion Criteria

  • 1\. Patients with other form of Tinea like Tinea capitus, Tinea onycomycosis etc.
  • 2\. Patients who are taking steroids, immuno\-suppressive or any cytotoxic medication.
  • 3\. Patients having other associated skin disease like secondary bacterial infection or suffering from auto immune diseases.
  • ââ?¬Â¢Pregnant or lactating women.

Outcomes

Primary Outcomes

Not specified

Similar Trials